SOLICITATION NOTICE
66 -- Four (4) each Genomic Sequencing Systems
- Notice Date
- 6/15/2026 2:03:15 PM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS Rockville MD 20852 USA
- ZIP Code
- 20852
- Solicitation Number
- RFQ-FDA-133845-133915
- Response Due
- 6/26/2026 7:00:00 AM
- Archive Date
- 06/27/2026
- Point of Contact
- Sarah Hussain
- E-Mail Address
-
Sarah.Hussain@fda.hhs.gov
(Sarah.Hussain@fda.hhs.gov)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- This acquisition is restricted to brand name or equal: Illumina MiSeq i100 Plus and Illumina DRAGENTM Bio-IT Platform because these systems will replace aging sequencers currently owned by the FDA. FDA needs continuity of maintaining the same sequencing methods, proprietary flow cells and reagents or equal, software licenses, and manufacturer-supported components necessary to operate mission driven project continuity. 1. Purpose The purpose of this procurement is to acquire four (4) Illumina MiSeq i100 Plus desktop genomic sequencing systems to support the FDA�s Human Foods Program (HFP). These systems will replace aging sequencers currently in use and enable high-throughput, cost-effective, and rapid sequencing critical for food safety surveillance, regulatory compliance, and the development of novel genomic applications. The acquisition directly supports FDA's mission to enhance public health through timely detection and characterization of foodborne pathogens in regulated products.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/642448c82b2d40f6b4527d20b47f8929/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN07852990-F 20260617/260615230054 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |